在患有德拉维特综合征的个体中控制发作的手术:这是一个安全和实用的选择吗?
Keith Starnes1, Elaine Wirrell1, M Scott Perry2
1Divisions of Child and Adolescent Neurology and Epilepsy, Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Expert review of neurotherapeutics
|September 18, 2025
概括
对德拉维特综合征的手术很少被考虑,但在某些情况下可能会减少发作. 神经调节,就像迷走神经刺激一样,对抗药性有潜在的益处.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 遗传学 是一个遗传学.
背景情况:
- 德拉维特综合征是一种严重的儿童脑病,其特征是耐药性和发育迟缓.
- 虽然医疗治疗已经改善了控制,但完全摆脱仍然是一个挑战.
- 德拉维特综合征背后的遗传通道病症通常使手术成为一种不常见的考虑.
研究的目的:
- 评估Dravet综合征手术干预的潜在益处,当显著的发作减少,而不是完全的发作自由是预期的结果.
- 审查关于德拉维特综合征和相似遗传性症疾病的手术治疗现有文献.
主要方法:
- 文献综述和专家意见综合.
- 对患有德拉维特综合征和类似遗传性的患者手术结果的分析.
主要成果:
- 手术通常不适用于德拉维特综合征,尽管患者很少是理想的候选人.
- 高度选择的病例可以通过手术方法实现有意义的发作减少.
- 神经调节程序,如迷走神经刺激,似乎是最有希望的减少发作.
结论:
- 虽然发作自由是难以捉摸的,但手术选择,特别是神经调节,可以在精心挑选的德拉维特综合征患者中显著减少发作.
- 需要进行进一步的研究,以确定手术后的发作减少是否转化为更广泛的非发作益处.
- 手术仍然是一个潜在的,尽管有限的,治疗途径,用于管理在德拉维特综合征中耐药性发作.
相关概念视频
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
831
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
831
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Electroconvulsive Therapy
916
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
916


